On the public citation graph
Comparison of Transplant Donor- and Third-Party Donor-Derived CMV-Specific T Cells for CMV Infection After Allogenic Stem Cell Transplantation
0 signed · 27 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1007/s00430-008-0093-2openalex-extracted
CD8 T-cell-based immunotherapy of cytomegalovirus infection: “proof of concept” provided by the murine model
inferredcites →https://doi.org/10.1016/j.bbmt.2015.05.015openalex-extracted
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia
inferredcites →https://doi.org/10.1016/s0140-6736(03)14634-xopenalex-extracted
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines
inferredcites →https://doi.org/10.1038/bmt.2016.17openalex-extracted
Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
inferredcites →https://doi.org/10.1038/leu.2017.16openalex-extracted
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
inferredcites →https://doi.org/10.1038/nri.2016.38openalex-extracted
T cell responses to cytomegalovirus
inferredcites →https://doi.org/10.1038/sj.bmt.1705445openalex-extracted
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies
inferredcites →https://doi.org/10.1056/nejm199510193331603openalex-extracted
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
inferredcites →https://doi.org/10.1080/21505594.2016.1221022openalex-extracted
CMV-specific immune reconstitution following allogeneic stem cell transplantation
inferredcites →https://doi.org/10.1084/jem.165.3.650openalex-extracted
In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection.
inferredcites →https://doi.org/10.1084/jem.20040613openalex-extracted
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers
inferredcites →https://doi.org/10.1093/cid/ciw668openalex-extracted
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.
inferredcites →https://doi.org/10.1093/cid/ciz368openalex-extracted
First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)–specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation
inferredcites →https://doi.org/10.1093/infdis/jix357openalex-extracted
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus
inferredcites →https://doi.org/10.1126/science.1352912openalex-extracted
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
inferredcites →https://doi.org/10.1128/jvi.61.10.3102-3108.1987openalex-extracted
CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity
inferredcites →https://doi.org/10.1128/jvi.62.3.1061-1065.1988openalex-extracted
Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors
inferredcites →https://doi.org/10.1182/blood-2010-01-262089openalex-extracted
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
inferredcites →https://doi.org/10.1182/blood-2012-08-448977openalex-extracted
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation
inferredcites →https://doi.org/10.1182/blood-2013-02-486324openalex-extracted
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
inferredcites →https://doi.org/10.1182/blood-2016-01-628982openalex-extracted
T cells for viral infections after allogeneic hematopoietic stem cell transplant
inferredcites →https://doi.org/10.1182/blood.v97.5.1232openalex-extracted
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
inferredcites →https://doi.org/10.1182/blood.v99.11.3916openalex-extracted
Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
inferredcites →https://doi.org/10.1182/bloodadvances.2017010223openalex-extracted
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
inferredcites →https://doi.org/10.1182/bloodadvances.2019000371openalex-extracted
“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients
inferredcites →https://doi.org/10.1182/bloodadvances.2020002735openalex-extracted
Adoptive therapy with CMV-specific cytotoxic T lymphocytes depends on baseline CD4+ immunity to mediate durable responses
inferredcites →https://doi.org/10.1186/s13045-018-0564-xopenalex-extracted
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.